Tuesday, May 31, 2016

Healthcare Tips: AC Immune files for U.S. IPO to develop Alzheimer's drug

(Reuters) - Swiss biotech firm AC Immune SA filed with U.S. regulators on Tuesday to raise up to $50 million in an initial public offering of common stock.

Read more: AC Immune files for U.S. IPO to develop Alzheimer's drug